Press release
September 9, 2026
Aktis Oncology to Present at Upcoming September Investor Conferences
Aktis Oncology, Inc. (AKTS)
BOSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today